Küpers clinical prediction score in a case series of primary aldosteronism

Authors

  • José Luis Paz-Ibarra Universidad Nacional Mayor de San Marcos, Lima, Perú
  • Marcio Concepcion-Zavaleta Universidad Privada Norbert Wiener, Lima, Perú
  • Jacsel Suarez-Rojas Universidad Científica del Sur, Lima, Perú
  • Anthony Ramos -Yataco Hospital Ricardo Cruzado Rivarola, Nazca, Perú
  • Carlos Alcalde-Loyola Universidad Nacional de Trujillo, Trujillo, Perú.
  • Sofía Ildefonso-Najarro Hospital Nacional Guillermo Almenara Irigoyen, Lima, Perú
  • Esteban Plasencia-Dueñas Hospital Nacional Guillermo Almenara Irigoyen, Lima, Perú
  • Pela Roseboom Hospital Regional Docente de Trujillo, Trujillo, Perú

DOI:

https://doi.org/10.35434/rcmhnaaa.2023.161.1609

Keywords:

Primary aldosteronism, hypertension, hypokalemia

Abstract

Background: Primary aldosteronism is a disorder due to excessive aldosterone production in the presence of low renin levels. It is an underdiagnosed pathology despite its simple screening. Establishing the unilateral or bilateral location represents the greatest diagnostic challenge and is crucial to define the therapeutic approach. Adrenal venous catheterization (AVC) is the best test to establish the location, but it is invasive and expensive. New predictive markers of laterality are being developed.

Case series presentation: We present a case series of 8 patients diagnosed with primary aldosteronism due to arterial hypertension with hypokalaemia, elevated aldosterone-renin ratio and compatible computed tomography. 4 patients underwent adrenal venous catheterization. Conclusion: In patients who underwent catheterization as well as in those who did not, the Küpers score adequately predicted lateralization in 75% of cases and it could be a useful tool to discriminate unilateral from bilateral aldosteronism.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

José Luis Paz-Ibarra, Universidad Nacional Mayor de San Marcos, Lima, Perú

1. Endocrinologist

Marcio Concepcion-Zavaleta, Universidad Privada Norbert Wiener, Lima, Perú

1. Endocrinologist

Jacsel Suarez-Rojas, Universidad Científica del Sur, Lima, Perú

1. Endocrinologist

Anthony Ramos -Yataco, Hospital Ricardo Cruzado Rivarola, Nazca, Perú

1. General physician

Carlos Alcalde-Loyola, Universidad Nacional de Trujillo, Trujillo, Perú.

1. General physician

Sofía Ildefonso-Najarro, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Perú

1. Endocrinologist

Esteban Plasencia-Dueñas, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Perú

1. Endocrinologist

Pela Roseboom, Hospital Regional Docente de Trujillo, Trujillo, Perú

1. Internist

References

Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018; 6:41–50. DOI: 10.1016/S2213-8587(17)30319-4

Käyser SC, Deinum J, de Grauw WJ, Schalk BW, Bor HJ, Lenders JW, et al. Prevalence of primary aldosteronism in primary care: a cross-sectional study. Br J Gen Pract. 2018 Feb;68(667):114-122. DOI: 10.3399/bjgp18X694589

Scholl UI. Hyperaldosteronismus [Hyperaldosteronism]. Internist (Berl). 2021 Mar;62(3):245-251. DOI: 10.1007/s00108-021-00972-8

Vaidya A, Carey RM. Evolution of the Primary Aldosteronism Syndrome: Updating the Approach, The Journal of Clinical Endocrinology & Metabolism, Volume 105, Issue 12, December 2020, Pages 3771–3783. DOI: 10.1210/clinem/dgaa606

Bird JB, Turcu AF, Auchus RJ. Primary aldosteronism: a practical approach to diagnosis and management. Circulation 2018; 138(8): 823-835. DOI: 10.1161/CIRCULATIONAHA.118.033597

Vaidya A, Mulatero P, Baudrand R, Adler GK. The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment. Endocr Rev 2018;39: 1057-88. DOI: 10.1210/er.2018-00139

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101: 1889 – 1916. DOI: 10.1210/jc.2015-4061

Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery, 2004; 136, 1227–1235. DOI: 10.1016/j.surg.2004.06.051

Oh EM, Lee KE, Yoon K, Kim SY, Kim HC, Youn YK. Value of adrenal venous sampling for lesion localization in primary aldosteronism. World Journal of Surgery, 2012; 36, 2522–2527. DOI: 10.1007/s00268-012-1695-9

Küpers, EM, Amar L, Raynaud A, Plouin PF, Steichen O. A clinical prediction score to diagnose unilateral primary aldosteronism. Journal of Clinical Endocrinology and Metabolism, 2012; 97, 3530– 3537. DOI: 10.1210/jc.2012-1917

Burrello J, Burrello A, Stowasser M, Nishikawa T, Quinkler M, Prejbisz A, et al. The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism. Ann Surg. 2020 Dec;272(6):1125-1132. DOI: 10.1097/SLA.0000000000003200

Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary Aldosteronism in patients in China with recently detected hypertension. J. Am. Coll. Cardiol. 2020, 75, 1913–1922. DOI: 10.1016/j.jacc.2020.02.052

Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, et al. Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism. J. Clin.Endocrinol. Metab. 2018, 103, 900–908. DOI: 10.1210/jc.2017-01774

Powlson AS, Gurnell M, Brown MJ. Nuclear imaging in the diagnosis of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes. 2015;22(3):150-156. DOI: 10.1097/MED.0000000000000148

Hennings J, Lindhe O, Bergström M, Langström B, Sundin A, Hellman P. 11C-metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab 2006; 91:1410–1414. DOI: 10.1210/jc.2005-2273

Burrello J, Amongero M, Buffolo F, Sconfienza E, Forestiero V, Burrello A, et al. Development of a Prediction Score to Avoid Confirmatory Testing in Patients with Suspected Primary Aldosteronism, The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 4, April 2021, Pages 1708–1716. DOI: 10.1210/clinem/dgaa974

Buffolo F, Monticone S, Williams TA, Rossato D, Burrello J, Tetti M, et al. Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary? Int. J. Mol. Sci. 2017, 18, 848. DOI: 10.3390/ijms18040848

Dekkers T, Prejbisz A, Kool LJ, Groenewoud HJ, Velema M, Spiering W, et al. SPARTACUS Investigators. Adrenal vein sampling versus CT scan to determine in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol. 2016; S2213-8587(16)30100-0. DOI: 10.1016/S2213-8587(16)30100-0

Beuschlein F, Mulatero P, Asbach E, Monticone S, Catena C, Sechi LA, et al. The SPARCTACUS trial: controversies and unresolved issues. Horm Metab Res 2017; 49: 936– 942. DOI: 10.1055/s-0043-120524

Williams TA, Gomez-Sanchez CE, Rainey WE, Giordano TJ, Lam AK, Marker A, et al. International Histopathology Consensus for Unilateral Primary Aldosteronism. J Clin Endocrinol Metab. 2021 Jan 1;106(1):42-5. DOI: 10.1210/clinem/dgaa484

Published

2023-06-11

How to Cite

1.
Paz-Ibarra JL, Concepcion-Zavaleta M, Suarez-Rojas J, Ramos -Yataco A, Alcalde-Loyola C, Ildefonso-Najarro S, Plasencia-Dueñas E, Roseboom P. Küpers clinical prediction score in a case series of primary aldosteronism . Rev. Cuerpo Med. HNAAA [Internet]. 2023 Jun. 11 [cited 2024 Nov. 27];16(1):155-9. Available from: https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1609

Recommended Articles